Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide

Journal of Experimental Medicine

Volumn 171, Issue 5, 1990, Pages 1815-1820

  Aichele, Peter ^a   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a   Schulz, Manfred ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; H-2 ANTIGENS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PEPTIDES; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; VACCINES; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0025287307     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.171.5.1815     Document Type: Article

References (18)

1. Zinkernagel, R. M., and P. C. Doherty. 1974. Restriction of in vitro T cells mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (Lond.). 248:701.
2. Braciale, T. J., L. A. Morrison, M. T. Sweetser, J. Sambrook, M. J. Gething, and V. L. Braciale. 1987. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98:95.
3. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:959.
4. Hosken, N. A., M. J. Bevan, and F. R. Carbone. 1989. Class I-restricted presentation 3 occurs without internalization or processing of exogenous antigenic peptides. J. Immunol. 142:1079.
5. Buchmeier, M. J., R. M. Welsh, F.J. Dutko, and M. B. A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275.
6. Staerz, U. D., H. Karasuyama, and A. M. Garner. 1987. Cytotoxic T lymphocytes against a soluble protein. Nature (Lond.). 329:449.
7. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
8. Ishioka, G. Y., S. Colon, C. Miles, H. M. Grey, and R. W. Chesnut. 1989. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo. J. Immunol. 143:1094.
9. Deres, K., H. Schild, K. H. Wiesmiiller, G.Jung, and H. G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (Lond.). 342:561.
10. Schulz, M., P. Aichele, M. Vollenweider, F. W. Bobe, F. Cardinaux, H. Hengartner, and R. M. Zinkernagel. 1989. MHC dependent T cell epitopes of LCMV nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657.
11. Whitton, J. L., A. Tishon, H. Lewicki, J. Gebhard, T. Cook, M. Salvato, E. Joly, and M. B. A. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303.
12. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
13. Merrifield, R. B. 1963. Peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149.
14. Stewart, J. M., and J. D. Young. 1982. Solid Phase Peptide Synthesis. W. H. Freeman Co., San Francisco.
15. Wang, S. S. 1973. p-alkoxybenzyl alcohol resin and p-alkoxybenzyloxy-carbonylhydrazide resin for solid phase synthesis of protected peptide fragments. J. Am. Chem. Soc. 95:1328.
16. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature (Lond.). 312:548.
17. Whitton, J. L., and M. B. A. Oldstone. 1989. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes. J. Exp. Med. 170:1033.
18. d gene acts as a restriction element for LCMV-specific killer T cells. Nature (Lond.). 297:415.